Both in Biotechnology
Liminatus Pharma vs Silexion Therapeutics
Over the past year LIMN returned −95.6% and SLXN returned −99.5%; their daily moves had a correlation of 0.01.
LIMN −95.6% SLXN −99.5%Growth of $1, one year, split-adjusted
| Metric | LIMN | SLXN |
|---|---|---|
| Price | $2.79 | $0.1535 |
| Market cap | $3.8M | $2.2M |
| Today | +0.16% | +0.10% |
| 1 month | −24.5% | −41.6% |
| 6 months | −72.7% | −97.3% |
| Year to date | −90.8% | −99.2% |
| 1 year | −95.8% | −99.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | — |
| Volatility (60d) | 1,152.5% | 228.2% |
| Short % of float | 4.6% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).